Zhu, Jiaqi
Salvatella, Xavier https://orcid.org/0000-0002-8371-4185
Robustelli, Paul https://orcid.org/0000-0002-9282-8993
Article History
Received: 7 January 2022
Accepted: 13 October 2022
First Online: 27 October 2022
Competing interests
: Paul Robustelli is an Open Science Fellow and scientific consultant of Roivant Discovery and a scientific advisor and consultant of Dewpoint Therapeutics. Xavier Salvatella is a founder and board member of Nuage Therapeutics. These affiliations have not influenced this work. The remaining authors declare no competing interests.